CompuGroup Medical SE KGaA Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de CompuGroup Medical SE KGaA de 28.8% y 3.8% por año respectivamente. Se prevé que el BPA crezca en un 28.7% al año. Se espera que la rentabilidad financiera sea de 13.5% en 3 años.
Información clave
27.2%
Tasa de crecimiento de los beneficios
26.9%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Healthcare Services | 28.1% |
Tasa de crecimiento de los ingresos | 3.9% |
Rentabilidad financiera futura | 16.7% |
Cobertura de analistas | Good |
Última actualización | 10 May 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital
Oct 27Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?
Oct 12At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?
Sep 04CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Aug 04Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Jul 16When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
May 31CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Dividend Of €0.50
Apr 24CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
Apr 10The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Mar 31What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Feb 25CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Jan 26Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 1,362 | 121 | 119 | 237 | 9 |
12/31/2025 | 1,292 | 109 | 119 | 223 | 9 |
12/31/2024 | 1,237 | 89 | 84 | 182 | 10 |
3/31/2024 | 1,220 | 50 | 93 | 162 | N/A |
12/31/2023 | 1,228 | 46 | 112 | 180 | N/A |
9/30/2023 | 1,247 | 76 | 135 | 201 | N/A |
6/30/2023 | 1,249 | 89 | 123 | 193 | N/A |
3/31/2023 | 1,214 | 70 | 82 | 157 | N/A |
12/31/2022 | 1,175 | 73 | 69 | 145 | N/A |
9/30/2022 | 1,127 | 72 | 45 | 122 | N/A |
6/30/2022 | 1,116 | 71 | 58 | 140 | N/A |
3/31/2022 | 1,088 | 76 | 88 | 165 | N/A |
12/31/2021 | 1,063 | 69 | 94 | 165 | N/A |
9/30/2021 | 1,021 | 66 | 88 | 155 | N/A |
6/30/2021 | 975 | 72 | 111 | 166 | N/A |
3/31/2021 | 915 | 71 | 113 | 168 | N/A |
12/31/2020 | 869 | 73 | 94 | 150 | N/A |
9/30/2020 | 833 | 77 | 86 | 128 | N/A |
6/30/2020 | 779 | 60 | 34 | 80 | N/A |
3/31/2020 | 781 | 58 | 60 | 107 | N/A |
12/31/2019 | 770 | 66 | 67 | 110 | N/A |
9/30/2019 | 757 | 87 | 83 | 137 | N/A |
6/30/2019 | 742 | 86 | 123 | 170 | N/A |
3/31/2019 | 747 | 97 | 109 | 155 | N/A |
12/31/2018 | 736 | 96 | 97 | 136 | N/A |
9/30/2018 | 707 | 65 | 73 | 112 | N/A |
6/30/2018 | 678 | 52 | 64 | 109 | N/A |
3/31/2018 | 624 | 39 | 61 | 101 | N/A |
12/31/2017 | 599 | 31 | N/A | 86 | N/A |
9/30/2017 | 586 | 41 | N/A | 89 | N/A |
6/30/2017 | 583 | 46 | N/A | 80 | N/A |
3/31/2017 | 578 | 47 | N/A | 78 | N/A |
12/31/2016 | 571 | 45 | N/A | 68 | N/A |
9/30/2016 | 562 | 41 | N/A | 67 | N/A |
6/30/2016 | 553 | 36 | N/A | 68 | N/A |
3/31/2016 | 556 | 27 | N/A | 55 | N/A |
12/31/2015 | 553 | 38 | N/A | 73 | N/A |
9/30/2015 | 548 | 34 | N/A | 41 | N/A |
6/30/2015 | 547 | 40 | N/A | 31 | N/A |
3/31/2015 | 535 | 42 | N/A | 35 | N/A |
12/31/2014 | 525 | 26 | N/A | 32 | N/A |
9/30/2014 | 511 | 29 | N/A | 55 | N/A |
6/30/2014 | 496 | 24 | N/A | 51 | N/A |
3/31/2014 | 479 | 18 | N/A | 45 | N/A |
12/31/2013 | 470 | 24 | N/A | 52 | N/A |
9/30/2013 | 462 | 19 | N/A | 50 | N/A |
6/30/2013 | 458 | 20 | N/A | 54 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (28.8% al año) de COP es superior a la tasa de ahorro (0.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (28.8% al año) de COP crezcan más rápidamente que el mercado German (14.8% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de COP crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (3.8% al año) de COP crezcan más despacio que el mercado de German (5.4% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 3.8% al año) de COP crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de COP sea baja dentro de 3 años (13.5%).